Yinglan Yu Selected Research

Yinglan Yu Research Topics

7	Neoplasms (Cancer) 01/2023 - 07/2018
2	Breast Neoplasms (Breast Cancer) 10/2020 - 10/2018
2	Dry Eye Syndromes (Dry Eye Syndrome) 11/2018 - 01/2018
1	Asthma (Bronchial Asthma) 01/2024
1	Colitis 09/2023
1	Pneumonia (Pneumonitis) 02/2023
1	Liver Neoplasms (Liver Cancer) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Inflammation (Inflammations) 03/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Bone Neoplasms (Bone Cancer) 01/2019
1	Weight Loss (Weight Reduction) 07/2018
1	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 01/2018

3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 01/2022
3	Therapeutic UsesIBA 01/2024 - 01/2019
3	MicellesIBA 12/2020 - 10/2018
2	LigandsIBA 02/2023 - 01/2022
2	Glutathione (Reduced Glutathione)IBA 01/2023 - 10/2020
2	Cell-Penetrating PeptidesIBA 03/2021 - 10/2018
2	NanoconjugatesIBA 10/2020 - 07/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 07/2018
2	PlatinumIBA 10/2020 - 07/2018
2	AcidsIBA 10/2018 - 07/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024
1	Polystyrenes (Polystyrene)IBA 09/2023
1	Sorafenib (BAY 43-9006)FDA Link 01/2023
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	Butyrates (Butyrate)IBA 01/2023
1	artemisinin (artemisinine)IBA 03/2021
1	Liposomes (Liposome)IBA 03/2021
1	Antimalarials (Antimalarial Agents)IBA 03/2021
1	deoxypodophyllotoxinIBA 12/2020
1	methoxy poly(ethylene glycol)-poly(lactide)IBA 12/2020
1	poly(lactide) (polylactic acid)IBA 12/2020
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2020
1	ProdrugsIBA 10/2020
1	Polyglutamic Acid (Polyglutamate)IBA 10/2020
1	Prostaglandins AIBA 10/2020
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2019
1	CurcuminIBA 01/2019
1	stearic acid (magnesium stearate)FDA LinkGeneric 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2018
1	ClathrinIBA 10/2018
1	PolymersIBA 10/2018
1	coumarinIBA 10/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2018

7	Therapeutics 02/2023 - 07/2018
1	Respiratory Therapy (Therapy, Respiratory) 01/2024
1	Intranasal Administration 02/2023
1	Oral Administration 01/2022